Post-pandemic Era Global Ion Channel Modulators Market Segment Research Report 2024
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Ion Channel Modulators market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Ion Channel Modulators market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Ion Channel Modulators production is XX (K Units). US market value in 2021 is about USD XX billion, and US Ion Channel Modulators production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Ion Channel Modulators production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Ion Channel Modulators Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Ion Channel Modulators Market?
Pfizer, Inc. (US)
Neusentis, Inc. (US)
AstraZeneca (UK)
Aurora Biomed, Inc. (Canada)
CalciMedica, Inc. (US)
Cellectricon AB (Sweden)
Convergence Pharmaceuticals Limited (UK)
Cytocentrics AG (Germany)
Evotec AG (Germany)
flyion GmbH (Germany)
GlaxoSmithKline Plc. (UK)
Nanion Technologies GmbH (Germany)
NeuroSearch A/S (Denmark)
Novartis AG (Switzerland)
Parion Sciences, Inc. (US)
Sanofi (France)
Targacept, Inc. (US)
Xention Limited (UK)
Zalicus, Inc. (US)
Major Type of Ion Channel Modulators Covered in MR Accuracy Reports report
Channel Blockers
Channel Openers
Application Segments Covered in MR Accuracy Reports Market
Clinical Trials
Hospital
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Ion Channel Modulators Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Ion Channel Modulators Market by Value
2.2.1 Global Ion Channel Modulators Revenue by Type
2.2.2 Global Ion Channel Modulators Market by Value (%)
2.3 Global Ion Channel Modulators Market by Production
2.3.1 Global Ion Channel Modulators Production by Type
2.3.2 Global Ion Channel Modulators Market by Production (%)
3. The Major Driver of Ion Channel Modulators Industry
3.1 Historical & Forecast Global Ion Channel Modulators Demand
3.2 Largest Application for Ion Channel Modulators (2017-2027)
3.3 The Major Downstream Company in China Market 2021
4. Global and Regional Ion Channel Modulators Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Ion Channel Modulators Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Ion Channel Modulators Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe Ion Channel Modulators Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China Ion Channel Modulators Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan Ion Channel Modulators Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India Ion Channel Modulators Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea Ion Channel Modulators Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia Ion Channel Modulators Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global Ion Channel Modulators Average Price Trend
12.1 Market Price for Each Type of Ion Channel Modulators in US (2017-2021)
12.2 Market Price for Each Type of Ion Channel Modulators in Europe (2017-2021)
12.3 Market Price for Each Type of Ion Channel Modulators in China (2017-2021)
12.4 Market Price for Each Type of Ion Channel Modulators in Japan (2017-2021)
12.5 Market Price for Each Type of Ion Channel Modulators in India (2017-2021)
12.6 Market Price for Each Type of Ion Channel Modulators in Korea (2017-2021)
12.7 Market Price for Each Type of Ion Channel Modulators in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
13.1 Ion Channel Modulators Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Ion Channel Modulators
14. Ion Channel Modulators Competitive Landscape
14.1 Pfizer, Inc. (US)
14.1.1 Pfizer, Inc. (US) Company Profiles
14.1.2 Pfizer, Inc. (US) Product Introduction
14.1.3 Pfizer, Inc. (US) Ion Channel Modulators Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Neusentis, Inc. (US)
14.2.1 Neusentis, Inc. (US) Company Profiles
14.2.2 Neusentis, Inc. (US) Product Introduction
14.2.3 Neusentis, Inc. (US) Ion Channel Modulators Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 AstraZeneca (UK)
14.3.1 AstraZeneca (UK) Company Profiles
14.3.2 AstraZeneca (UK) Product Introduction
14.3.3 AstraZeneca (UK) Ion Channel Modulators Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Aurora Biomed, Inc. (Canada)
14.4.1 Aurora Biomed, Inc. (Canada) Company Profiles
14.4.2 Aurora Biomed, Inc. (Canada) Product Introduction
14.4.3 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 CalciMedica, Inc. (US)
14.5.1 CalciMedica, Inc. (US) Company Profiles
14.5.2 CalciMedica, Inc. (US) Product Introduction
14.5.3 CalciMedica, Inc. (US) Ion Channel Modulators Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Cellectricon AB (Sweden)
14.6.1 Cellectricon AB (Sweden) Company Profiles
14.6.2 Cellectricon AB (Sweden) Product Introduction
14.6.3 Cellectricon AB (Sweden) Ion Channel Modulators Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 Convergence Pharmaceuticals Limited (UK)
14.7.1 Convergence Pharmaceuticals Limited (UK) Company Profiles
14.7.2 Convergence Pharmaceuticals Limited (UK) Product Introduction
14.7.3 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 Cytocentrics AG (Germany)
14.8.1 Cytocentrics AG (Germany) Company Profiles
14.8.2 Cytocentrics AG (Germany) Product Introduction
14.8.3 Cytocentrics AG (Germany) Ion Channel Modulators Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 Evotec AG (Germany)
14.9.1 Evotec AG (Germany) Company Profiles
14.9.2 Evotec AG (Germany) Product Introduction
14.9.3 Evotec AG (Germany) Ion Channel Modulators Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
14.10 flyion GmbH (Germany)
14.10.1 flyion GmbH (Germany) Company Profiles
14.10.2 flyion GmbH (Germany) Product Introduction
14.10.3 flyion GmbH (Germany) Ion Channel Modulators Sales, Revenue (2017-2021)
14.10.4 Strategic initiatives
14.11 GlaxoSmithKline Plc. (UK)
14.12 Nanion Technologies GmbH (Germany)
14.13 NeuroSearch A/S (Denmark)
14.14 Novartis AG (Switzerland)
14.15 Parion Sciences, Inc. (US)
14.16 Sanofi (France)
14.17 Targacept, Inc. (US)
14.18 Xention Limited (UK)
14.19 Zalicus, Inc. (US)
15. Conclusion
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Ion Channel Modulators Industry (Volume)
Figure 2. Ion Channel Modulators Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Ion Channel Modulators Revenue in 2021
Figure 5. US Ion Channel Modulators Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Ion Channel Modulators Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Ion Channel Modulators Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Ion Channel Modulators Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Ion Channel Modulators Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Ion Channel Modulators Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Ion Channel Modulators Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Ion Channel Modulators Revenue, by Type (Million USD) (2017-2027)
Table 4. Ion Channel Modulators Production, by Type (K Unit) (2017-2027)
Table 5. Ion Channel Modulators Demand (K Unit) by Application (2017-2027)
Table 6. Ion Channel Modulators Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Ion Channel Modulators Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Ion Channel Modulators Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Ion Channel Modulators Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Ion Channel Modulators Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Ion Channel Modulators Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Ion Channel Modulators Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Ion Channel Modulators Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Ion Channel Modulators Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Ion Channel Modulators in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Ion Channel Modulators in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Ion Channel Modulators in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Ion Channel Modulators in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Ion Channel Modulators in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Ion Channel Modulators in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Ion Channel Modulators in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Pfizer, Inc. (US) Profiles
Table 61. Pfizer, Inc. (US) Ion Channel Modulators Product Introduction
Table 62. Pfizer, Inc. (US) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. Pfizer, Inc. (US) Strategic initiatives
Table 64. Neusentis, Inc. (US) Profiles
Table 65. Neusentis, Inc. (US) Ion Channel Modulators Product Introduction
Table 66. Neusentis, Inc. (US) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Neusentis, Inc. (US) Strategic initiatives
Table 68. AstraZeneca (UK) Profiles
Table 69. AstraZeneca (UK) Ion Channel Modulators Product Introduction
Table 70. AstraZeneca (UK) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. AstraZeneca (UK) Strategic initiatives
Table 72. Aurora Biomed, Inc. (Canada) Profiles
Table 73. Aurora Biomed, Inc. (Canada) Ion Channel Modulators Product Introduction
Table 74. Aurora Biomed, Inc. (Canada) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. Aurora Biomed, Inc. (Canada) Strategic initiatives
Table 76. CalciMedica, Inc. (US) Profiles
Table 77. CalciMedica, Inc. (US) Ion Channel Modulators Product Introduction
Table 78. CalciMedica, Inc. (US) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. CalciMedica, Inc. (US) Strategic initiatives
Table 80. Cellectricon AB (Sweden) Profiles
Table 81. Cellectricon AB (Sweden) Ion Channel Modulators Product Introduction
Table 82. Cellectricon AB (Sweden) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. Cellectricon AB (Sweden) Strategic initiatives
Table 84. Convergence Pharmaceuticals Limited (UK) Profiles
Table 85. Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Product Introduction
Table 86. Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. Convergence Pharmaceuticals Limited (UK) Strategic initiatives
Table 88. Cytocentrics AG (Germany) Profiles
Table 89. Cytocentrics AG (Germany) Ion Channel Modulators Product Introduction
Table 90. Cytocentrics AG (Germany) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. Cytocentrics AG (Germany) Strategic initiatives
Table 92. Evotec AG (Germany) Profiles
Table 93. Evotec AG (Germany) Ion Channel Modulators Product Introduction
Table 94. Evotec AG (Germany) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 95. Evotec AG (Germany) Strategic initiatives
Table 97. flyion GmbH (Germany) Profiles
Table 98. flyion GmbH (Germany) Ion Channel Modulators Product Introduction
Table 99. flyion GmbH (Germany) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 100. flyion GmbH (Germany) Strategic initiatives
Table 101. GlaxoSmithKline Plc. (UK) Profiles
Table 102. GlaxoSmithKline Plc. (UK) Ion Channel Modulators Product Introduction
Table 103. GlaxoSmithKline Plc. (UK) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 104. GlaxoSmithKline Plc. (UK) Strategic initiatives
Table 105. Nanion Technologies GmbH (Germany) Profiles
Table 106. Nanion Technologies GmbH (Germany) Ion Channel Modulators Product Introduction
Table 107. Nanion Technologies GmbH (Germany) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 108. Nanion Technologies GmbH (Germany) Strategic initiatives
Table 109. NeuroSearch A/S (Denmark) Profiles
Table 110. NeuroSearch A/S (Denmark) Ion Channel Modulators Product Introduction
Table 111. NeuroSearch A/S (Denmark) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 112. NeuroSearch A/S (Denmark) Strategic initiatives
Table 113. Novartis AG (Switzerland) Profiles
Table 114. Novartis AG (Switzerland) Ion Channel Modulators Product Introduction
Table 115. Novartis AG (Switzerland) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 116. Novartis AG (Switzerland) Strategic initiatives
Table 117. Parion Sciences, Inc. (US) Profiles
Table 118. Parion Sciences, Inc. (US) Ion Channel Modulators Product Introduction
Table 119. Parion Sciences, Inc. (US) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 120. Parion Sciences, Inc. (US) Strategic initiatives
Table 121. Sanofi (France) Profiles
Table 122. Sanofi (France) Ion Channel Modulators Product Introduction
Table 123. Sanofi (France) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 124. Sanofi (France) Strategic initiatives
Table 125. Targacept, Inc. (US) Profiles
Table 126. Targacept, Inc. (US) Ion Channel Modulators Product Introduction
Table 127. Targacept, Inc. (US) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 128. Targacept, Inc. (US) Strategic initiatives
Table 129. Xention Limited (UK) Profiles
Table 130. Xention Limited (UK) Ion Channel Modulators Product Introduction
Table 131. Xention Limited (UK) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Table 132. Xention Limited (UK) Strategic initiatives
Table 133. Zalicus, Inc. (US) Profiles
Table 134. Zalicus, Inc. (US) Ion Channel Modulators Product Introduction
Table 135. Zalicus, Inc. (US) Ion Channel Modulators Sales (Unit), Revenue (Million USD) (2017-2021)
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices